DKSH Entrusted by Ministry of Health to Supply COVID-19 Treatment Pill in Cambodia

DKSH has been appointed by Cambodia’s Ministry of Health to supply Molnupiravir, the first oral medication for COVID-19 in Cambodia.

Cambodia, Phnom Penh, December 13, 2021 – DKSH Business Unit Healthcare, Asia’s leading partner for healthcare companies seeking to grow their business in Asia and beyond, has been appointed as an official supplier of Molnupiravir, antiviral medication for COVID-19 patients, by the Cambodian Ministry of Health, starting December 3, 2021.

 

Under this agreement, DKSH Cambodia is the first in the country to supply over four million capsules of Molnupiravir to treat 100,000 patients in public and private hospitals as well as clinics and pharmacies across Cambodia. Molnupiravir is an antiviral pill that inhibits the replication of certain RNA viruses and is used to treat COVID -19. It is the first oral medicine in the world to be approved for use against COVID-19. The drug is administered to patients with mild-to-moderate COVID-19 symptoms within five days of their onset.

 

Dr. Sim Sokchan, Representative of the Technical Working Group in Research of Anti-COVID-19 Drug in Cambodia, commented: “DKSH Cambodia has been serving the Cambodian healthcare industry for many years. With a highly professional and dedicated team that has worked relentlessly to support our healthcare sector, we are confident that DKSH is the right partner to supply us the medicine, while maintaining the highest quality standards and distributing products to all corners of the country. Thanks to this cooperation with DKSH, we believe patients across our country will have access to this critical COVID-19 treatment.”

 

Sandeep Tewari, Vice President, Healthcare in Cambodia and Laos, said: “DKSH is one of the largest healthcare providers in the country and as such, we have been entrusted by the public and private healthcare sector with many projects. We deliver on our promise of enriching people’s lives and preserve the quality and safety of products under our care according to stringent quality standards. We are known for providing reliable and safe cold chain services under good distribution practice and quality assurance standards for essential deliveries like the COVID-19 vaccines, COVID-19 Rapid Tests, and now also the COVID-19 medical treatment Molnipiravir. We are greatly honored that we have been entrusted with providing the first oral COVID-19 treatment to patients across Cambodia.”

 

 

For further information, please contact:

 

DKSH Cambodia Ltd.

Chanreasey Chum

Manager, Branding & Communications

Phone +855 23 212 838

chanreasey.chum@dksh.com